CI vs IBIO · P/E 2.4, rev $274.90B vs rev $100.0K
Cigna Corp (CI) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the CI and IBIO stock pages for the full models.
Not investment advice.